Location
Headquarters: Wayne, Pennsylvania, United States, North America
Region: Pennsylvania
Country: US
Continent: North America
About
Veranova is a global provider of development and manufacturing services for specialist and complex active pharmaceutical ingredients (APIs) used by pharma and biotech customers. The company emphasizes CDMO capabilities across discovery, development, reformulation, and large-scale manufacturing, with a focus on solid-form science, crystallization, particle engineering, and analytical development. Headquartered with a global footprint, Veranova supports clinical and commercial API production, regulatory compliance, and lifecycle management to help customers advance pharmaceutical programs.
Veranova is a global contract development and manufacturing organization (CDMO) specializing in complex active pharmaceutical ingredients (APIs). The company serves pharmaceutical and biotech clients by providing services ranging from discovery and development to large-scale manufacturing, with a focus on solid-form science and particle engineering. Headquartered in Pennsylvania, it operates facil
Veranova, L.P.
2022
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Late Stage
unknown
private
Leadership
Matteo Villain — Vice President of Peptides and Oligonucleotides
Victoria Brown — Sr.Vice President and Chief Human Resources Officer
Jose Ibietatorremendia — SVP, General Counsel, and Secretary
Rohtash Kumar — SVP, Development Operations & Chief Technical Officer
Thomas Rohrer — Vice President of Bioconjugation
Cécile Maupas — Sr. Vice President & Chief Commercial Officer
Scott Lassonde — Sr. Vice President & Chief Financial Officer
Technology Stack
Products
Custom Pharma CDMO Solutions: Contract development and manufacturing services for pharmaceutical active ingredients, supporting drug development from pre-clinical to commercialization stages.
Chromatography Services: Preparative chromatography and purification services for APIs, including impurity isolation, chiral separations, and scale-up to GMP manufacturing.
Analytical Method Development: Development and validation of analytical methods for pharmaceutical compounds from early clinical research to GMP scale-up and commercialization.
Solid Form Sciences: Expertise in polymorphs, salt forms, crystal morphology, and particle engineering to support solid form development of APIs.
Quality, Compliance and Regulatory Affairs: Quality management, compliance, and regulatory support to ensure pharmaceutical products meet global standards and regulatory requirements.
Technology Transfer: Support for scale-up and technology transfer processes to enable efficient transition from development to commercial manufacturing.
Funding rounds
Acquired · (2022-06-01)